Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy

Area of Science:

• Oncology
• Radiation Oncology
• Hematology

Background:

• Diffuse large B-cell lymphoma (DLBCL) is the most prevalent non-Hodgkin lymphoma subtype.
• Advanced stage (III/IV) DLBCL affects approximately 50% of patients.
• R-CHOP remains the standard treatment, but improvements have been limited.

Purpose of the Study:

• To evaluate the efficacy of consolidation radiation therapy (RT) in advanced DLBCL.
• To identify patient subgroups that may benefit most from consolidation RT.
• To assess the impact of RT on local disease control and overall outcomes.

Main Methods:

• Review of retrospective and prospective data on consolidation RT in advanced DLBCL.
• Analysis of outcomes in patients receiving RT alongside systemic therapy.
• Stratification of patients based on disease characteristics (e.g., bulky disease, bone involvement) and response to therapy.

Main Results:

• Consolidation RT demonstrates improved outcomes in select advanced DLBCL patients.
• RT is particularly effective for bulky disease, bone involvement, or partial response to systemic therapy.
• Radiation therapy significantly enhances local disease control.

Conclusions:

• Consolidation RT is a valuable addition to systemic therapy for specific advanced DLBCL cases.
• RT improves overall outcomes by achieving superior local disease control.
• Further investigation into optimal patient selection for consolidation RT is warranted.